{
  "author": {
    "name": "Phil Galewitz Kaiser Health News Phil Galewitz Kaiser Health News",
    "webUrl": "/author/profile/phil-galewitz-kaiser-health-news-phil-galewitz-kaiser-health-news/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2021/06/03/no-timeline-to-advance-drug-imports-from-canada-under-biden-administration/",
        "title": "No timeline to advance drug imports from Canada under Biden administration",
        "byline": "Phil Galewitz, Kaiser Health News\n\nPhil Galewitz, Kaiser Health News",
        "kicker": "News",
        "prettyDate": "June 03, 2021",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/11/joe_biden.jpg",
          "width": "290",
          "height": "174"
        },
        "authors": [
          {
            "webUrl": "/author/profile/phil-galewitz-kaiser-health-news-phil-galewitz-kaiser-health-news/",
            "name": "Phil Galewitz, Kaiser Health News Phil Galewitz, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The Biden administration said states still have several hurdles to get through, including a review by the FDA.",
        "body": null
      }
    ]
  }
}